These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30580153)

  • 1. Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer.
    Yang J; Yin H; Yang J; Wei Y; Fang L; Chai D; Zhang Q; Zheng J
    Transl Oncol; 2019 Mar; 12(3):453-461. PubMed ID: 30580153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer.
    Yang J; Yang J; Wei Y; Yin H; Fang L; Chai D; Li H; Li H; Zhang Q; Zheng J
    Int Immunopharmacol; 2019 May; 70():125-134. PubMed ID: 30798161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC.
    Zhang Y; Yang J; Ding M; Li L; Lu Z; Zhang Q; Zheng J
    Oncol Lett; 2016 Nov; 12(5):3241-3249. PubMed ID: 27899989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
    Sha H; Zou Z; Xin K; Bian X; Cai X; Lu W; Chen J; Chen G; Huang L; Blair AM; Cao P; Liu B
    J Control Release; 2015 Feb; 200():188-200. PubMed ID: 25553823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD.
    Fadeev R; Chekanov A; Solovieva M; Bezborodova O; Nemtsova E; Dolgikh N; Fadeeva I; Senotov A; Kobyakova M; Evstratova Y; Yakubovskaya R; Akatov V
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Yan F; Wang S; Yang W; Goldberg SN; Wu H; Duan WL; Deng ZT; Han HB; Zheng HR
    Radiology; 2017 Nov; 285(2):462-471. PubMed ID: 28631963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.
    Singh T; Kim TW; Murthy ASN; Paul M; Sepay N; Jeong Kong H; Sung Ryu J; Rim Koo N; Yoon S; Song KH; Jun Baek M; Jeon S; Im J
    Eur J Med Chem; 2024 Feb; 265():116050. PubMed ID: 38128233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.
    Sugahara KN; Scodeller P; Braun GB; de Mendoza TH; Yamazaki CM; Kluger MD; Kitayama J; Alvarez E; Howell SB; Teesalu T; Ruoslahti E; Lowy AM
    J Control Release; 2015 Aug; 212():59-69. PubMed ID: 26071630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer.
    Zhu A; Sha H; Su S; Chen F; Wei J; Meng F; Yang Y; Du J; Shao J; Ji F; Zhou C; Zou Z; Qian X; Liu B
    Am J Cancer Res; 2018; 8(1):91-105. PubMed ID: 29416923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
    Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
    Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting.
    Lingasamy P; Laarmann AH; Teesalu T
    Curr Cancer Drug Targets; 2021; 21(1):70-79. PubMed ID: 33001014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
    Hu C; Huang Y; Chen Y
    Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased antitumor activity of tumor-specific peptide modified thymopentin.
    Lao X; Li B; Liu M; Chen J; Gao X; Zheng H
    Biochimie; 2014 Dec; 107 Pt B():277-85. PubMed ID: 25236717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin.
    Nemudraya AA; Makartsova AA; Fomin AS; Nushtaeva AA; Koval OA; Richter VA; Kuligina EV
    PLoS One; 2016; 11(8):e0160980. PubMed ID: 27513518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment.
    Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B
    Sci Rep; 2017 Apr; 7(1):579. PubMed ID: 28373646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.
    Puig-Saus C; Rojas LA; Laborda E; Figueras A; Alba R; Fillat C; Alemany R
    Gene Ther; 2014 Aug; 21(8):767-74. PubMed ID: 24942629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
    Peng ZH; Kopeček J
    J Am Chem Soc; 2015 Jun; 137(21):6726-9. PubMed ID: 25963409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Penetrating Peptide-Functionalized Redox-Responsive Hyperbranched Poly(amido amine) Delivering siRNA for Lung Cancer Therapy.
    Guo Z; Li S; Liu Z; Xue W
    ACS Biomater Sci Eng; 2018 Mar; 4(3):988-996. PubMed ID: 33418781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An iRGD peptide fused superantigen mutant induced tumor-targeting and T lymphocyte infiltrating in cancer immunotherapy.
    Song Y; Xu M; Li Y; Li Y; Gu W; Halimu G; Fu X; Zhang H; Zhang C
    Int J Pharm; 2020 Aug; 586():119498. PubMed ID: 32505575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
    E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.